Available for public comment: Measuring Overuse: Maximizing Usefulness and Minimizing Unintended Consequences

The American Medical Association (AMA)-convened Physician Consortium for Performance Improvement® (PCPI®) is initiating a 35-day public comment period for the white paper entitled: Measuring Overuse: Maximizing Usefulness and Minimizing Unintended Consequences.

The PCPI Measure Implementation Evaluation (MIE) Advisory Committee, under the leadership of Robert Bonow, MD, convened a sub-workgroup to develop a white paper focused on identifying overuse, constructing overuse measures, and minimizing their potential unintended consequences. The Overutilization workgroup was led by MIE Advisory Committee member David Baker, MD, MPH and consisted of Mark L. Metersky, MD; Helen Burstin, MD, MPH; Joseph Drozda Jr., MD, FACC; Jeffrey Linder, MD, MPH, FACP; Jay Schurr, MD; Jason Mathias, MD; Joanne Cuny, RN, MBA; Greg Wozniak, PhD; Laura Yodice, MHA, MPH; and Keri Christensen, MS.

The development and proper implementation of overuse measures have the potential to be an integral part of the solution to the cost, quality, and safety problems in the U.S. health care system. This white paper offers a set of principles for the development and execution of overuse measures intended to maximize their utility as well as minimize the potential for unintended consequences. Increasing the usefulness of overuse measures is recommended and guidelines for measure developers are offered. It is of particular significance that measure developers take specific considerations and actions to prevent unintended consequences of overuse measures and mitigate the possibility of adverse occurrences.

Please feel free to forward this document to others within your organization or constituency who may offer insight and expertise. All comments are welcome and will be shared with our internal team for consideration.

This white paper is available for review and submission of comments. The 35-day public comment period will close at 5:00p.m. CST on Wednesday, January 16, 2013.

* 1. Your contact information, including your e-mail address, will not be shared, sold, traded, exchanged or rented. See our privacy policy page for more information.

* 2. Please indicate if your comments represent your individual opinion, or are on behalf of an organization.

* 3. Please indicate the type of organization with which you are affiliated.

* 4. All persons submitting public comments on the Measuring Overuse: Maximizing Usefulness and Minimizing Unintended Consequences white paper must report, along with their comments, any disclosable interests they may have relevant to the subject of the discussion. A “disclosable interest” is any personal or financial interest or affiliation that a reasonable person would consider relevant to the evaluation of the individual’s comments. If the person submitting public comments has no “disclosable interests” they shall affirmatively state that they have no “disclosable interests".